Privo Technologies Inc

Inspiring women to do what works best for them, follow their ambitions, and be OK with less conventional ways. Success comes from within!

Thrilled to announce that Privo Technologies, Inc. has been awarded a chance to collaborate with the prestigious Nanotechnology Characterization Lab's (NCL)! NCL's program is a pivotal step in promoting the clinical translation of our novel therapies. Each quarter, the NCL selects the most promising cancer nanomedicine candidates, and we are honored to be among them. NCI established the Nanotechnology Characterization Laboratory (NCL) to accelerate the progress of nanomedicine by providing resources and a knowledge base. It is a collaborative effort between the awardees, NCI, the US Food and Drug Administration (FDA), and the National Institute of Standards and Technology (NIST).  Grateful for this opportunity to advance our mission of bringing transformative therapies to those who need them most. Here's to the next chapter in our journey! https://lnkd.in/eY-grrpC #PrivoTechnologies #Innovation #Nanomedicine #ClinicalTranslation #ResearchAdvancement #nanotechnology #Oncology

Join #Privo’s team as we kick off the year in San Fransisco alongside the JP Morgan Healthcare Conference! Our CEO, Manijeh Goldberg will be meeting with wonderful colleagues and friends January 8-11th. Learn more about our new and exciting PRV131- Intratumoral Injectable that has shown great promise in preclinical studies: https://lnkd.in/eTGSTWhM

Thrilled to announce that Privo Technologies, Inc. has been awarded a chance to collaborate with the prestigious Nanotechnology Characterization Lab's (NCL)! NCL's program is a pivotal step in promoting the clinical translation of our novel therapies. Each quarter, the NCL selects the most promising cancer nanomedicine candidates, and we are honored to be among them. NCI established the Nanotechnology Characterization Laboratory (NCL) to accelerate the progress of nanomedicine by providing resources and a knowledge base. It is a collaborative effort between the awardees, NCI, the US Food and Drug Administration (FDA), and the National Institute of Standards and Technology (NIST).  Grateful for this opportunity to advance our mission of bringing transformative therapies to those who need them most. Here's to the next chapter in our journey! https://lnkd.in/eY-grrpC #PrivoTechnologies #Innovation #Nanomedicine #ClinicalTranslation #ResearchAdvancement #nanotechnology #Oncology

Join #Privo’s team as we kick off the year in San Fransisco alongside the JP Morgan Healthcare Conference! Our CEO, Manijeh Goldberg will be meeting with wonderful colleagues and friends January 8-11th. Learn more about our new and exciting PRV131- Intratumoral Injectable that has shown great promise in preclinical studies: https://lnkd.in/eTGSTWhM

Join #Privo’s team as we kick off the year in San Fransisco alongside the JP Morgan Healthcare Conference! Our CEO, Manijeh Goldberg will be meeting with wonderful colleagues and friends January 8-11th. Learn more about our new and exciting PRV131- Intratumoral Injectable that has shown great promise in preclinical studies: https://lnkd.in/eTGSTWhM

THANK YOU FOR SHOWING UP FOR ME 🙏 I am speechless, teary-eyed and eternally grateful for the way that my professional network and some complete strangers showed up for me and my family last weekend. I was running against time to save the life of my daughter’s dad (Luis) after he was diagnosed with Stage 4 Tongue Cancer and was told that his only hope for survival was to get his entire tongue surgically removed, leaving him on a feeding tube, unable to speak, swallow, and taste. If not for all you amazing humans, Luis would have lost his tongue by now. Instead, we got on a plane ✈️ to Chicago Monday night and had a string of appointments on Tuesday with an incredible team of doctors at University of Chicago Medicine 🏥 - the only hospital in the country that cures his type and stage of cancer with a non-surgical, organ-sparing approach with success rates comparable to surgery. As a result, Luis is starting his custom treatment plan tomorrow, which will require him to stay in Chicago for approximately 6 months and possibly longer. This is a miraculous first win 🌟! But it’s just the beginning of a very difficult journey. It will be grueling. It will be painful. But he is young, strong 💪, and in great shape otherwise, and he will beat this thing with the love ❤️ and support of his family and friends!!! To ease the financial burden on Luis, we have organized a fundraiser for him on GoFundMe (link below). The funds will be used for the portion of the treatment not covered by insurance, lodging and travel expenses for Luis and his caretakers as he is undergoing treatment in Chicago. Please comment, share 🔄, and like 👍 for wider reach to make sure we get Luis the support he needs as he is fighting for his life. Again - THANK YOU FOR BEING AMAZING HUMANS 🤝❤️!!!!! Special thanks to Manijeh Goldberg, PhD, Nishant Agrawal, Amy MacDougall (Hurwitz), Ph.D., Tom Chavez, Caryn Finley and everyone else who rallied behind us on a weekend (some while on a family vacation overseas) and took the time to make such a huge difference in our lives ❤️ ❤️ ❤️ 🙏 🙏 🙏 #Gratitude #CancerFight #StrengthInCommunity #MedicalMiracle #NonSurgicalTreatment #CancerAwareness #HealthJourney #FamilySupport https://gofund.me/25d64a19